From infections and allergies to brain diseases and autoimmune disorders, a wave of trials offers hope ...

Researchers are testing CAR T-cell therapy as a treatment for lupus, Graves’ disease and other conditions in which the body’s ...

New research presented at the American College of Rheumatology (ACR) annual meeting contributed to the growing body of evidence highlighting the elevated risks of non-Hodgkin lymphoma and other ...

An experimental pill has shown unprecedented success in treating pancreatic cancer, upending conventional wisdom about the disease.

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were most notable in people with alopecia areata and Sjögren syndrome. Findings ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate ...

The End Brain Cancer Initiative (EBCI) announced its 2026 recipient of the National HOPE Award: Becky Moroney, a ...

Scientists found that leaking mitochondrial RNA helps pancreatic tumors survive, revealing a promising new treatment target.

Earlier initiation of average-risk screening at age 45 reflects increasing concern about younger-onset colorectal cancer ...

Discover how genetic fatty liver combined with diabetes and obesity significantly increases liver cancer risk, according to a ...